At Piedmont Heart’s Napa Cardiology Conference, Dr. Julio Palmaz, inventor of the first commercially available stent in the U.S., shares his thoughts on what’s next in medicine. Nanotechnology could revolutionize the way devices such as coronary stents are made. “Results would be that devices would be highly refined, the rejection rates would be low and hopefully the costs would be driven down too,” he says. piedmont.org/valvelearning